Prothena Corporation PLCNASDAQ:PRTA
- LAST PRICE20.5600
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots16.0000/ 2
- Ask / Lots20.8800/ 1
- Open / Previous Close0.0000 / 20.5600
- Day Range---
- 52 Week Range
- Volume30
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | PRTA |
|---|---|---|
| 09:32 ET | 4057 | 20.285 |
| 09:34 ET | 900 | 20 |
| 09:36 ET | 800 | 19.88 |
| 09:38 ET | 100 | 19.88 |
| 09:39 ET | 400 | 19.805 |
| 09:41 ET | 200 | 19.75 |
| 09:43 ET | 900 | 19.87 |
| 09:45 ET | 300 | 19.9 |
| 09:48 ET | 345 | 19.85 |
| 09:50 ET | 400 | 19.8 |
| 09:52 ET | 1300 | 19.96 |
| 09:54 ET | 800 | 19.9 |
| 09:56 ET | 300 | 19.82 |
| 09:57 ET | 900 | 19.76 |
| 09:59 ET | 1550 | 19.68 |
| 10:01 ET | 1200 | 19.67 |
| 10:03 ET | 300 | 19.69 |
| 10:06 ET | 600 | 19.77 |
| 10:08 ET | 500 | 19.83 |
| 10:10 ET | 400 | 19.79 |
| 10:12 ET | 700 | 19.87 |
| 10:14 ET | 500 | 19.86 |
| 10:15 ET | 3100 | 19.88 |
| 10:17 ET | 200 | 19.93 |
| 10:19 ET | 200 | 19.93 |
| 10:21 ET | 700 | 19.905 |
| 10:24 ET | 1600 | 20.04 |
| 10:26 ET | 100 | 20.005 |
| 10:28 ET | 1300 | 20.065 |
| 10:30 ET | 100 | 20.11 |
| 10:32 ET | 1500 | 20.06 |
| 10:33 ET | 400 | 20.05 |
| 10:35 ET | 1100 | 19.88 |
| 10:37 ET | 450 | 19.9499 |
| 10:42 ET | 814 | 19.905 |
| 10:44 ET | 1900 | 19.95 |
| 10:46 ET | 100 | 19.96 |
| 10:48 ET | 400 | 19.95 |
| 10:50 ET | 800 | 20.04 |
| 10:51 ET | 300 | 20 |
| 10:53 ET | 1300 | 20.05 |
| 10:55 ET | 400 | 20.08 |
| 10:57 ET | 200 | 20.07 |
| 11:00 ET | 800 | 20.145 |
| 11:02 ET | 300 | 20.19 |
| 11:04 ET | 800 | 20.14 |
| 11:06 ET | 1000 | 20.135 |
| 11:08 ET | 200 | 20.12 |
| 11:09 ET | 500 | 20.16 |
| 11:11 ET | 200 | 20.17 |
| 11:13 ET | 200 | 20.165 |
| 11:15 ET | 1000 | 20.16 |
| 11:20 ET | 1808 | 20.21 |
| 11:22 ET | 100 | 20.23 |
| 11:24 ET | 3300 | 20.255 |
| 11:26 ET | 900 | 20.285 |
| 11:27 ET | 200 | 20.26 |
| 11:29 ET | 700 | 20.22 |
| 11:31 ET | 800 | 20.14 |
| 11:33 ET | 800 | 20.11 |
| 11:36 ET | 800 | 20.1 |
| 11:38 ET | 400 | 20.13 |
| 11:40 ET | 400 | 20.145 |
| 11:42 ET | 20341 | 20.395 |
| 11:44 ET | 2200 | 20.31 |
| 11:45 ET | 300 | 20.3 |
| 11:47 ET | 1100 | 20.35 |
| 11:49 ET | 300 | 20.33 |
| 11:51 ET | 900 | 20.35 |
| 11:54 ET | 400 | 20.29 |
| 11:56 ET | 300 | 20.23 |
| 11:58 ET | 500 | 20.23 |
| 12:00 ET | 200 | 20.29 |
| 12:02 ET | 100 | 20.28 |
| 12:03 ET | 200 | 20.28 |
| 12:05 ET | 200 | 20.27 |
| 12:07 ET | 1400 | 20.34 |
| 12:09 ET | 700 | 20.33 |
| 12:12 ET | 500 | 20.29 |
| 12:14 ET | 200 | 20.28 |
| 12:16 ET | 100 | 20.29 |
| 12:18 ET | 500 | 20.31 |
| 12:20 ET | 344 | 20.28 |
| 12:21 ET | 1088 | 20.31 |
| 12:25 ET | 300 | 20.305 |
| 12:30 ET | 300 | 20.33 |
| 12:32 ET | 2750 | 20.395 |
| 12:34 ET | 500 | 20.37 |
| 12:36 ET | 900 | 20.37 |
| 12:38 ET | 600 | 20.365 |
| 12:39 ET | 100 | 20.34 |
| 12:41 ET | 826 | 20.4 |
| 12:45 ET | 926 | 20.4 |
| 12:50 ET | 1100 | 20.435 |
| 12:52 ET | 800 | 20.46 |
| 12:56 ET | 200 | 20.469 |
| 12:57 ET | 300 | 20.48 |
| 01:01 ET | 200 | 20.46 |
| 01:03 ET | 300 | 20.455 |
| 01:06 ET | 300 | 20.48 |
| 01:08 ET | 800 | 20.49 |
| 01:10 ET | 400 | 20.51 |
| 01:12 ET | 400 | 20.5 |
| 01:14 ET | 1500 | 20.48 |
| 01:15 ET | 300 | 20.47 |
| 01:17 ET | 500 | 20.42 |
| 01:19 ET | 400 | 20.44 |
| 01:21 ET | 550 | 20.445 |
| 01:24 ET | 400 | 20.38 |
| 01:26 ET | 200 | 20.41 |
| 01:28 ET | 800 | 20.41 |
| 01:30 ET | 297 | 20.435 |
| 01:32 ET | 800 | 20.44 |
| 01:33 ET | 600 | 20.475 |
| 01:35 ET | 100 | 20.49 |
| 01:37 ET | 200 | 20.49 |
| 01:39 ET | 1200 | 20.521 |
| 01:42 ET | 200 | 20.59 |
| 01:46 ET | 200 | 20.58 |
| 01:48 ET | 500 | 20.635 |
| 01:50 ET | 100 | 20.61 |
| 01:51 ET | 200 | 20.64 |
| 01:55 ET | 100 | 20.655 |
| 01:57 ET | 1911 | 20.64 |
| 02:00 ET | 1560 | 20.63 |
| 02:04 ET | 500 | 20.59 |
| 02:06 ET | 400 | 20.565 |
| 02:08 ET | 800 | 20.6 |
| 02:11 ET | 200 | 20.61 |
| 02:13 ET | 100 | 20.615 |
| 02:15 ET | 305 | 20.61 |
| 02:20 ET | 400 | 20.595 |
| 02:22 ET | 300 | 20.595 |
| 02:24 ET | 1500 | 20.6 |
| 02:26 ET | 200 | 20.59 |
| 02:29 ET | 1908 | 20.575 |
| 02:31 ET | 700 | 20.59 |
| 02:33 ET | 1000 | 20.565 |
| 02:36 ET | 100 | 20.55 |
| 02:38 ET | 100 | 20.54 |
| 02:40 ET | 100 | 20.5375 |
| 02:42 ET | 700 | 20.51 |
| 02:44 ET | 100 | 20.48 |
| 02:45 ET | 1000 | 20.49 |
| 02:47 ET | 400 | 20.5 |
| 02:56 ET | 2000 | 20.58 |
| 02:58 ET | 700 | 20.61 |
| 03:00 ET | 300 | 20.59 |
| 03:02 ET | 500 | 20.59 |
| 03:03 ET | 300 | 20.62 |
| 03:05 ET | 300 | 20.67 |
| 03:07 ET | 200 | 20.63 |
| 03:09 ET | 400 | 20.6 |
| 03:12 ET | 1300 | 20.6 |
| 03:18 ET | 2722 | 20.555 |
| 03:20 ET | 509 | 20.54 |
| 03:21 ET | 1100 | 20.6 |
| 03:23 ET | 500 | 20.59 |
| 03:25 ET | 200 | 20.595 |
| 03:27 ET | 500 | 20.61 |
| 03:30 ET | 3107 | 20.65 |
| 03:32 ET | 1400 | 20.64 |
| 03:34 ET | 622 | 20.62 |
| 03:36 ET | 1800 | 20.59 |
| 03:38 ET | 2400 | 20.565 |
| 03:39 ET | 1855 | 20.515 |
| 03:41 ET | 1100 | 20.53 |
| 03:43 ET | 1700 | 20.515 |
| 03:45 ET | 1800 | 20.47 |
| 03:48 ET | 2300 | 20.5 |
| 03:50 ET | 5569 | 20.525 |
| 03:52 ET | 2110 | 20.535 |
| 03:54 ET | 2161 | 20.58 |
| 03:56 ET | 12658 | 20.5 |
| 03:57 ET | 8304 | 20.5103 |
| 03:59 ET | 150913 | 20.56 |
Apr 15, 2024
Prothena Announces Review on Birtamimab Mechanism of Action and Pharmacological Characteristics Published in Leukemia & Lymphoma, from 4:05PM ET on Monday Apr 15, 2024 by Dow Jones
4:05PM ET on Monday Apr 15, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Prothena Corporation PLC | 1.1B | -7.3x | --- |
Vir Biotechnology Inc | 1.0B | -1.7x | --- |
Immatics NV | 1.0B | -7.6x | --- |
Arcutis Biotherapeutics Inc | 987.4M | -2.2x | --- |
SAGE Therapeutics Inc | 816.2M | -1.6x | --- |
Regenxbio Inc | 787.6M | -2.7x | --- |
Company Information
Prothena Corporation plc is an Ireland-based late-stage clinical biotechnology company. The Company is engaged in protein dysregulation and a pipeline of investigational therapeutics for rare peripheral amyloid diseases. The Company is advancing a pipeline of therapeutic candidates for a range of indications and targets to integrate scientific insights around neurological dysfunction and the biology of misfolded proteins. The Company’s pipeline includes both wholly owned and partnered programs being developed for the potential treatment of diseases, including AL amyloidosis, ATTR amyloidosis, Alzheimer’s disease, Parkinson’s disease and a range of other neurodegenerative diseases. Its clinical programs include birtamimab for the potential treatment of AL amyloidosis, prasinezumab for the potential treatment of Parkinson’s disease, NNC6019/PRX004 for the potential treatment of ATTR amyloidosis, and PRX005 and PRX012 for the potential treatment of Alzheimer’s disease.
Contact Information
- Headquarters
- 77 Sir John Rogersons Quay Block C, Grand Canal DocklandsDUBLIN, Ireland D02 T804
- Phone
- ---
- Fax
- ---
Executives
- Independent Chairman of the Board
- Lars Ekman
- Chief Operating Officer, Chief Scientific Officer, Head - Research and Development
- Gene Kinney
- Chief Financial Officer, Chief Strategy Officer
- Tran Nguyen
- Chief Operating Officer
- Brandon Smith
- Chief Accounting Officer
- Karin Walker
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.1B |
|---|---|
Revenue (TTM) | $91.4M |
Shares Outstanding | 53.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.30 |
EPS | $-2.80 |
Book Value | $10.46 |
P/E Ratio | -7.3x |
Price/Sales (TTM) | 12.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -209.08% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
